NFG
OREX

Next Financial Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Next Financial Group’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-140
Closed – – 1969
2016
Q1 		$0 Sell
140
-275
-66% -$3.57K ﹤0.01% 2004
2015
Q4 		$7K Sell
415
-440
-51% -$10.5K ﹤0.01% 1322
2015
Q3 		$18K Buy
855
+50
+6% +$1.71K 0.01% 1006
2015
Q2 		$39K Buy
805
+280
+53% +$16.7K 0.01% 767
2015
Q1 		$41K Sell
525
-20
-4% -$1.24K 0.01% 740
2014
Q4 		$33K Sell
545
-120
-18% -$6.03K 0.01% 811
2014
Q3 		$28K Buy
+665
New +$35.7K 0.01% 1236

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Next Financial Group's OREX Position: Q2 2016 in Review

Next Financial Group sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2016, closing a stake of 140 shares.

Next Financial Group first reported a position in OREX in Q3 2014 and held it in 7 quarters. The position peaked at $41K in Q1 2015. 73 funds tracked by Wall St. Rank hold OREX as of Q2 2016.

  • Next Financial Group reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • Next Financial Group sold 140 Orexigen Therapeutics, Inc. shares in Q2 2016.
  • Next Financial Group first reported a position in Orexigen Therapeutics, Inc. in Q3 2014 and held it in 7 quarters.
  • Next Financial Group's Orexigen Therapeutics, Inc. position peaked at $41K in Q1 2015.
  • 73 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2016.

Based on Next Financial Group's 13F filing for Q2 2016, filed 7 Jul 2016.